Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.53 USD | -8.38% | -15.00% | +30.77% |
Mar. 18 | Clearside Biomedical Names Victor Chong Chief Medical Officer | MT |
Mar. 18 | Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer | CI |
Evolution of the average Target Price on Clearside Biomedical, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Clearside Biomedical, Inc.
Wedbush | |
JonesTrading Institutional Services | |
JMP Securities | |
Needham & Co. | |
Stifel Nicolaus | |
HC Wainwright | |
Roth Capital Partners |
EPS Revisions
- Stock
- Equities
- Stock Clearside Biomedical, Inc. - Nasdaq
- Consensus Clearside Biomedical, Inc.